Psychopharmacological treatments of somatoform disorders

By Altamura A.C.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 176-177

Elsevier

Access to resources Recommend Favorite

Substance Abuse and Movement Disorders

By  

Current Drug Abuse Reviews, Vol. 2, Iss. 3, 2009-09 ,pp. : 273-278

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Glycogen Synthase Kinase-3 in the CNS: Implications for the Development of New Treatments for Mood Disorders

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1399-1409

Bentham Science Publishers

Access to resources Recommend Favorite

PET and SPECT Exploration of Central Monoaminergic Transporters for the Development of New Drugs and Treatments in Brain Disorders

By  

Current Pharmaceutical Design, Vol. 11, Iss. 25, 2005-10 ,pp. : 3237-3245

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Chelators for the Twenty First Century: New Treatments for Iron and Copper Mediated Inflammatory and Neurological Disorders

By  

Current Drug Delivery, Vol. 2, Iss. 3, 2005-01 ,pp. : 261-268

Bentham Science Publishers

Access to resources Recommend Favorite